Sched.com Conference Mobile Apps
FierceBiotech 3rd Drug Development Forum
has ended
Create Your Own Event
Menu
Schedule
Speakers
Search
Log in
Sign up
FierceBiotech 3rd Drug Development Forum
-
Saved To My Sched
Schedule
Simple
Expanded
Grid
By Venue
Speakers
Search
or browse by date + venue
General Session
Networking
TRACK — Breakthroughs in Guiding Early-Stage Research
TRACK — Strategic Deal-Making & Partnering
Workshop
Girish Aakalu
IPSEN
VP, Global Head of External Innovation
Andrew Allen
GRITSTONE ONCOLOGY
CEO
Karen Anderson
ALNYLAM PHARMACEUTICALS
Senior Vice President, Chief Human Resources Officer
Roy Baynes
MERCK
CMO, Senior Vice President, Head of Clinical Development
Caroline Stark Beer
ALNYLAM PHARMACEUTICALS
Vice President, Head of Business Development
Samuel Blackman
SILVERBACK THERAPEUTICS
Senior Vice President, Head of Clinical Development
Lawrence Bloch
INFINITY PHARMACEUTICALS
President
Natalia Borinshteyn
ABBVIE
former Vice President, Medical Affairs, HCV Launch Team
Richard Brudnick
CODIAK BIOSCIENCES
Chief Business Officer, Head of Strategy
Christine Carberry
KERYX BIOPHARMA
COO
Judy Chuk
ENZYVANT
Vice President, Strategy & Operations
Paula Cobb
DECIBEL THERAPEUTICS
Executive Vice President, Corporate Development
Jean-Philippe Combal
VIVET THERAPEUTICS
CEO
Ramzi Dagher
PFIZER
Vice President, Worldwide Safety and Regulatory, and Regulatory Head,...
Brad Dickerson
AURINIA PHARMACEUTICALS
General Manager Americas and Global Product Assessment
Jim Doherty
SAGE THERAPEUTICS
Chief Research Officer
Celia Economides
AURINIA PHARMACEUTICALS
Vice President, Corporate & Public Affairs
JE
Jeffrey Ellison
CLARK ELBING LLP
Partner
David Elmaleh
AZTHERAPIES
CEO
Doug Fambrough
DICERNA PHARMACEUTICALS
CEO
Neal Farber
NEUROHEALING PHARMACEUTICALS
CEO
Maria Fardis
IOVANCE
CEO
Wolfgang Fischer
AFFIMED
COO
BG
Barbara Goodman
CURES WITHIN REACH
COO
CH
Conor Hale
FIERCEBIOTECH
Associate Editor
Amit Hasija
FULCRUM THERAPEUTICS
CFO
Kate Haviland
BLUEPRINT MEDICINES
CBO
CH
Carly Helfand
FIERCEMARKETS
Senior Editor
Ronald Herbst
MEDIMMUNE
Vice President, R&D, Head of Oncology Research
Steven Holtzman
DECIBEL THERAPEUTICS
CEO
Randy Hubbell
CARMELL THERAPEUTICS
CEO
Nouhad Husseini
REGENERON
Vice President, Head of Business Development
Amirah Al Idrus
FIERCEBIOTECH
Editor
Amri Johnson
NOVARTIS
Global Head, Diversity and Inclusion
Ravi Kiron
EMD SERONO
Head, BioPharma External Innovation
David Benshoof Klein
CLICK THERAPEUTICS
CEO
DK
Darshan Kulkarni
SYNCHROGENIX
Principal Attorney, KULKARNI LAW FIRM; Vice President, Regulatory...
LL
Leslie Leahy
OVID THERAPEUTICS
Vice President, Head of Medical Sciences
Bruce Leicher
MOMENTA
Senior Vice President and General Counsel
Liz Lewis
TAKEDA
Chief Counsel, Head of Patient Advocacy
TL
Thomas Loeser
ORIGENIS
CFO
Kevin Lynch
RECURSION PHARMACEUTICALS
CBO
Lori Lyons-Williams
DERMIRA
Chief Commercial Officer
Kennen MacKay
RBC CAPITAL MARKETS
Managing Director, US Biotech Equity Research
Ana Maiques
NEUROELECTRICS
CEO
Holly May
SOBI
Vice President, Sales and Marketing
Kevin McArdle
CHEETAH MEDICAL
CFO
Sean McCarthy
CYTOMX
CEO
Lisa McKerracher
BIOAXONE BIOSCIENCES
CEO
Agustin Melian
ALEXION PHARMACEUTICALS
Senior Vice President, Global Medical Sciences
Joseph Menetski
FNIH BIOMARKERS CONSORTIUM
Associate Vice President
Bobbie Mount
NIH
Program Officer
LN
Lauren Neighbours
PSI-CRO
Head, Regulatory Affairs
Brad Prosek
CONSTELLATION PHARMACEUTICALS
Senior Vice President, Corporate Development
Chandra Ramanathan
BAYER
Vice President and Head, East Coast Innovation Center
Sridhar Ramaswamy
TESARO
Vice President, Translational R&D
Sanuj Ravindran
PELLEPHARM
CEO
Debanjan Ray
CYTOMX
CFO
Jake Reder
CELDARA MEDICAL
CEO
Jason Rhodes
ATLAS VENTURE
Partner
Carol Robertson-Plouch
CONVERGENCE BIOSCIENCE
Founder
Issi Rozen
BROAD INSTITUTE
CBO
Stefan Scherer
CELLECTIS
Senior Vice President, Clinical Development, Deputy CMO
Thomas Schuetz
COMPASS THERAPEUTICS
CEO
Marc Schwabish
FUSION PHARMACEUTICALS
Senior Vice President, BD and US Operations
Kim Seth
REPARE THERAPEUTICS
Executive Vice President, Head of Business and Corporate Development
David Sherris
GENADAM THERAPEUTICS
CEO
David Shoemaker
RHO
Senior Vice President, R&D
Neal Simon
AZEVAN PHARMACEUTICALS
CEO
Ruchita Sinha
SANOFI VENTURES
Senior Director of Investments
PS
Peter Smith
H3 BIOMEDICINE
CSO
TS
Trevor Smith
GE HEALTHCARE
R&D Technology Lead, Cell & Gene Therapy
Catherine Sohn
BIOECLIPSE THERAPEUTICS
Chairman
Jeremy Sohn
NOVARTIS
Vice President, Global Head of Digital Business Development &...
Brenda Sousa
CONSTELLATION PHARMACEUTICALS
Senior Vice President, Human Resources and Operations
Robert Stanislaro
FTI CONSULTING
Managing Director
Ricky Sun
BAIN CAPITAL
Principal, Life Science Fund
Adrienne Takacs
ELI LILLY
former COO, Senior Director, R&D Operations
Praveen Tipirneni
MORPHIC THERAPEUTICS
CEO
Timothy Tracy
APRECIA PHARMACEUTICALS
CEO
GV
Geeta Vemuri
AGENT CAPITAL
Managing Partner
Thomas De Vlaam
AMYLON THERAPEUTICS
CEO
Alex Waldron
PEAR THERAPEUTICS
Chief Commercial Officer
Stephen Webster
SPARK THERAPEUTICS
CFO
Yaron Werber
OVID THERAPEUTICS
CFO/CBO
BZ
Brett Zbar
FORESITE CAPITAL MANAGEMENT
Managing Director
Joseph Zenkus
PFIZER
Senior Director, Worldwide Business Development
Martine Zimmerman
ALEXION PHARMACEUTICALS
Senior Vice President, Global Regulatory Affairs